NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-282-2016-2-SG-18 Methods For Pre-conditioning Patients For Cell Therapy SG National Stage 11201709424U Pending
NCI E-282-2016-2-SA-17 Methods For Pre-conditioning Patients For Cell Therapy SA National Stage 517390394 Pending
NCI E-150-2017-2-TT-15 Diagnostic Methods For T Cell Therapy TT National Stage TT/a/2017/00166 Abandoned
NCI E-282-2016-2-UA-31 Methods For Pre-conditioning Patients For Cell Therapy UA National Stage 201712872 Pending
NCI E-150-2017-2-UA-27 Diagnostic Methods For T Cell Therapy UA National Stage a201712961 Pending
NCI E-282-2016-2-TT-19 Methods For Pre-conditioning Patients For Cell Therapy TT National Stage TT/A/2017/00165 Abandoned
NIDDK E-742-2013-0-US-05 A3 Adenosine Receptor Agonists US National Stage 15/039,778 9963450 Issued PDF
NIDDK E-011-2014-0-US-08 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer US National Stage 15/039,781 Abandoned
NIDDK E-742-2013-0-GB-12 A3 Adenosine Receptor Agonists GB EP 14815994.0 Issued
NIDDK E-742-2013-0-IT-13 A3 Adenosine Receptor Agonists IT EP 14815994.0 Issued
NIDDK E-742-2013-0-ES-10 A3 Adenosine Receptor Agonists ES EP 14815994.0 Issued
NIDDK E-742-2013-0-EP-04 A3 Adenosine Receptor Agonists EP National Stage 14815994.0 Issued
NIDDK E-742-2013-0-DE-09 A3 Adenosine Receptor Agonists DE EP 14815994.0 Issued
NIDDK E-742-2013-0-FR-11 A3 Adenosine Receptor Agonists FR EP 14815994.0 Issued
NIAID E-170-2013-1-US-05 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION US National Stage 15/039,384 10246505 Issued PDF
NICHD E-552-2013-0-US-12 Adeno-Associated Virus Vectors for Treatment of Glycogen Storage Disease US National Stage 15/038,979 9644216 Issued PDF
NCI E-257-2009-1-AU-14 Use Of IL-15 To Increase Thymic Output and to Treat Lymphopenia AU DIV 2016203362 Issued
NHLBI E-089-2013-1-US-01 Culture Medium For Stem Cell Differentiation US CIP 15/160,650 Abandoned
NCI E-096-2017-0-PCT-02 NEXT-GENERATION SEQUENCING-BASED GENOTYPING ASSAY FOR HUMAN PAPILLOMA VIRUS (HPV) PCT PCT PCT/US16/033437 Expired
NHLBI E-045-2019-0-US-01 Free Breathing Motion Corrected Pixel-wise Mri Myocardial T1 Parameter Mapping US ORD 15/155,205 10264994 Issued PDF
NHGRI E-007-1999-2-JP-11 Cellular Arrays and Methods of Detecting and Using Genetic Disorder Markers JP DIV 2016-97711 Expired
NINR E-134-2015-0-PCT-02 POINT OF NEED TESTING DEVICE AND METHODS OF USE THEREOF PCT PCT PCT/US16/032788 Expired
NCI E-087-2015-1-DE-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs DE EP 16725323.6 Issued
NCI E-087-2015-1-FR-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs FR EP 16725323.6 Issued
NCI E-087-2015-1-CH-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs CH EP 16725323.6 Issued
NCI E-087-2015-1-GB-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs GB EP 16725323.6 Issued
NCI E-087-2015-1-EP-02 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs EP National Stage 16725323.6 Issued
NCI E-087-2015-1-ES-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs ES EP 16725323.6 Issued
NIDDK E-064-2004-0-US-58 The Use Of Leptin For Treating Human Lipotrophy US CON 15/154,749 Abandoned
NHLBI E-516-2013-0-US-03 Detection of Atherosclerotic Cardiovascular Disease Risk US National Stage 15/036,751 Abandoned
NCI E-771-2013-4-CN-10 Modified Pseudomonas Exotoxin A CN National Stage 201480062185.7 Issued
NCI E-087-2015-1-PCT-01 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs PCT PCT COMB PCT/US16/032317 Expired
NIDCR E-175-2015-1-FR-08 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone FR EP 16727258.2 Issued
NIDCR E-175-2015-1-DE-07 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone DE EP 16727258.2 Issued
NIDCR E-175-2015-1-EP-03 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone EP National Stage 16727258.2 Issued
NIDCR E-175-2015-1-GB-09 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone GB EP 16727258.2 Issued
NIDCR E-175-2015-1-PCT-01 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone PCT PCT COMB PCT/US2016/032047 Expired
NCI E-179-2015-0-PCT-02 Methods for the Treatment or Prevention of Ischemic Tissue Damage PCT PCT PCT/US2016/032194 Abandoned
NCI E-178-2015-0-PCT-02 Synthetic Immunosuppressive Oligodeoxynucleotides Reduce Ischemic Tissue Damage PCT PCT PCT/US2016/032192 Abandoned
NCATS E-751-2013-0-US-03 Method of Blocking Transmission of Malarial Parasite US National Stage 15/036,355 Abandoned
NIDCR E-175-2015-1-CA-02 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone CA National Stage 2985786 Issued
NCI E-029-2006-1-AU-14 N-Substituted indenoisoquinolines and syntheses thereof AU DIV 2016203107 Abandoned
NIAMS E-762-2013-1-US-02 Engineering Neural Stem Cells using Homologous Recombination US National Stage 15/035,958 Pending
NHLBI E-078-2015-0-CN-05 Three-Dimensional Right Atrial Appendage Curve Catheter CN National Stage 201680027776.X Issued
NHLBI E-078-2015-0-PCT-02 Three-Dimensional Right Atrial Appendage Curve Catheter PCT PCT PCT/US2016/031461 Expired
NHLBI E-078-2015-0-EP-03 Three-Dimensional Right Atrial Appendage Curve Catheter EP National Stage 16796939.3 Pending
NCI E-750-2013-0-US-09 Method For Subtyping Lymphoma Types by Means of Expression Profiling US National Stage 15/035,101 10607717 Issued PDF
NCI E-750-2013-0-JP-07 Methods for Subtyping Lymphoma Types by Means of Expression Profiling JP National Stage 2016-553231 Issued
NHLBI E-259-2007-0-US-05 Nitrite And Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes US CON 15/146,190 Pending
NIAID E-004-2009-2-US-15 METHODS FOR THE INDUCTION OF IMMUNE RESPONSES IN A SUBJECT COMPRISING ADMINISTERING VIRUS-LIKE PARTICLES (VLPS) PREPARED FROM CHIKUNGUNYA VIRUS STRUCTURAL PROTEINS US DIV 15/145,483 10369208 Issued PDF